Skip to main content
. 2022 Nov 6;42(12):1314–1330. doi: 10.1002/cac2.12385

FIGURE 3.

FIGURE 3

Subgroup analysis of overall survival, showing the overall survival benefits in the overall population and across subgroups. Note: For brain metastases, as there were patients with missing data of brain metastases at baseline in the sintilimab arm and docetaxel arm, respectively, the total number of events plus non‐events did not equal to 109 and 105, respectively.

Abbreviations: ECOG, Eastern Cooperative Oncology Group; PS, performance status; PD‐L1, programmed cell death ligand‐1; TPS, tumor proportion score; HR, hazard ratio; CI, confidence interval.